Company intelligence / Profile preview

ReGen Ventures

Byron Bay, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

ReGen Ventures is an active, early-stage venture capital firm investing primarily in regenerative technologies across climate tech, biomanufacturing, materials science, and clean energy. It does not discover, develop, or commercialize drugs or health therapies directly, but rather funds startups (including in synthetic biology/biomanufacturing) that have the potential for environmental and planetary health impact[1][7][9][11].

Industry: Investors

Beyond the preview

Go deeper on ReGen Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReGen Ventures.

Explore the full profile